OpGen Inc (NASDAQ:OPGN)
| 1.19 Delayed Data As of Dec 05 |  -0.07 / -5.56%Today’s Change | 0.92 Today|||52-Week Range 40.60 | -95.42% Year-to-Date |
Latest OPGN News | Press Releases
No recent news for OpGen Inc.
Today’s Trading
| Previous close | 1.26 |
| Today’s open | 1.27 |
| Day’s range | 1.16 - 1.33 |
| Volume | 218,033 |
| Average volume (3 months) | 486,580 |
| Market cap | $6.8M |
Data as of 3:59pm ET, 12/05/2019
Growth & Valuation
| Earnings growth (last year) | +77.29% |
| Earnings growth (this year) | +81.46% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -8.24% |
| P/E ratio | NM |
| Price/Sales | 2.65 |
| Price/Book | 0.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTOProteon Therapeutics... | -0.01 | -3.45% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 3:45pm ET, 12/05/2019
Financials
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $2.9M |
| Annual profit (last year) | -$13.4M |
| Net profit margin | -453.72% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
